Kamal Hamed's Insider Trades & SAST Disclosures

Kamal Hamed's most recent trade in Spero Therapeutics Inc was a trade of 239,731 Common Stock done . Disclosure was reported to the exchange on Feb. 1, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Spero Therapeutics Inc
Hamed Kamal Chief Medical Officer 01 Feb 2024 239,731 816,192 (4%) 1% 0 Common Stock
Spero Therapeutics Inc
Hamed Kamal Chief Medical Officer 01 Feb 2024 28,075 788,117 (4%) 0% 1.4 38,463 Common Stock
Spero Therapeutics Inc
Kamal Hamed Chief Medical Officer 12 Jun 2023 140,000 615,957 (3%) 0% 0 Common Stock
Spero Therapeutics Inc
Kamal Hamed Chief Medical Officer 01 Feb 2023 265,957 475,957 (2%) 1% 0 Common Stock
Spero Therapeutics Inc
Kamal Hamed Chief Medical Officer 12 Sep 2022 210,000 210,000 (1%) 1% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades